Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong · Delayed Price · Currency is HKD 47.50
-0.80 (-1.66%)
Sep 11, 2026, 4:08 PM HKT
HKG:6609 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 513.79 | 408.29 | 277.9 | 232.34 | 183.03 | 90.09 | |
Revenue Growth | 53.40% | 46.92% | 19.61% | 26.94% | 103.17% | 518.66% |
Cost of Revenue | 160.24 | 136.12 | 104.24 | 80.55 | 59.15 | 35.14 |
Gross Profit | 353.55 | 272.17 | 173.66 | 151.79 | 123.88 | 54.95 |
Selling, General & Admin | 214.23 | 187.12 | 137.81 | 153.88 | 167.99 | 135.01 |
Research & Development | 41.12 | 40.76 | 58.94 | 123.83 | 153.69 | 76.31 |
Other Operating Expenses | 8.65 | 0.01 | 10.26 | 0.95 | 1.82 | 3.21 |
Operating Expenses | 263.99 | 227.89 | 207 | 278.66 | 323.5 | 214.53 |
Operating Income | 89.56 | 44.27 | -33.34 | -126.87 | -199.62 | -159.58 |
Interest Expense | -1.68 | -2.06 | -1.75 | -2.16 | -2.15 | -2.36 |
Interest & Investment Income | 5.23 | 6.24 | 8.77 | 11.2 | 15.14 | 5.5 |
Earnings From Equity Investments | - | - | - | - | -34.8 | - |
Currency Exchange Gain (Loss) | -2.02 | -2.02 | 1.17 | 1.4 | 8.3 | -22.28 |
Other Non Operating Income (Expenses) | 15.18 | 16.17 | 8.79 | 11.21 | 11.88 | -23.02 |
EBT Excluding Unusual Items | 106.27 | 62.6 | -16.36 | -105.22 | -201.25 | -201.74 |
Gain (Loss) on Sale of Investments | 8.24 | 27.26 | 4.37 | 0.93 | - | 3.84 |
Gain (Loss) on Sale of Assets | -4.18 | -3.46 | - | 1.37 | - | - |
Pretax Income | 110.33 | 86.41 | -11.99 | -102.92 | -201.25 | -197.91 |
Income Tax Expense | 17.57 | 3.07 | 1.63 | -8.91 | -0.87 | - |
Earnings From Continuing Operations | 92.76 | 83.34 | -13.62 | -94.01 | -200.38 | -197.91 |
Minority Interest in Earnings | - | - | - | - | - | 3.68 |
Net Income | 92.76 | 83.34 | -13.62 | -94.01 | -200.38 | -194.23 |
Net Income to Common | 92.76 | 83.34 | -13.62 | -94.01 | -200.38 | -194.23 |
Net Income Growth | 118.60% | - | - | - | - | - |
Shares Outstanding (Basic) | 38 | 38 | 38 | 38 | 38 | 33 |
Shares Outstanding (Diluted) | 38 | 38 | 38 | 38 | 38 | 33 |
Shares Change | -1.47% | 0.47% | -0.81% | -0.51% | 14.60% | 52.84% |
EPS (Basic) | 2.47 | 2.21 | -0.36 | -2.47 | -5.24 | -5.82 |
EPS (Diluted) | 2.47 | 2.20 | -0.36 | -2.47 | -5.24 | -5.82 |
EPS Growth | 121.15% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 142.55 | -7.27 | -92.98 | -303.28 | -258.69 |
Free Cash Flow Per Share | - | 3.76 | -0.19 | -2.44 | -7.92 | -7.75 |
Gross Margin | 68.81% | 66.66% | 62.49% | 65.33% | 67.68% | 60.99% |
Operating Margin | 17.43% | 10.84% | -12.00% | -54.60% | -109.06% | -177.13% |
Profit Margin | 18.05% | 20.41% | -4.90% | -40.46% | -109.48% | -215.59% |
Free Cash Flow Margin | - | 34.91% | -2.62% | -40.02% | -165.70% | -287.14% |
EBITDA | 109.02 | 64.43 | -9.87 | -102.57 | -173.68 | -152.15 |
EBITDA Margin | 21.22% | 15.78% | -3.55% | -44.14% | -94.89% | -168.88% |
D&A For EBITDA | 19.46 | 20.16 | 23.47 | 24.3 | 25.94 | 7.43 |
EBIT | 89.56 | 44.27 | -33.34 | -126.87 | -199.62 | -159.58 |
EBIT Margin | 17.43% | 10.84% | -12.00% | -54.60% | -109.06% | -177.13% |
Effective Tax Rate | 15.92% | 3.56% | - | - | - | - |